• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG SELF TEST 2CT; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG SELF TEST 2CT; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. Back to Search Results
Catalog Number 195-160
Device Problem Non Reproducible Results (4029)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/22/2024
Event Type  malfunction  
Event Description
The consumer reported conflicting results with the binaxnow covid-19 antigen self-test performed on (b)(6) 2024 using tests from the same lot.The consumer stated the first test generated a positive result and the second test generated a negative result.No other testing was performed.The consumer stated the patient was asymptomatic.The customer confirmed there was no patient harm due to the test results.No additional patient information, including treatment and outcome, was provided.
 
Manufacturer Narrative
D4 udi: (b)(4).The investigation remains in progress.A supplemental report will be provided after completion or upon receipt of new information.Single-use, device discarded.
 
Manufacturer Narrative
D4 udi: (b)(4).Testing was performed at abbott diagnostics scarborough, inc.On retained kit lot 218193 with internal positive quality control samples and negative quality control swabs.All test results were valid and performed as expected.Additionally, the manufacturing records and quality control release testing was reviewed for test kit part number 195-160/ lot 218193, test base part number 195-430h/ lot 214611.The lot met the required release specifications.A review of the complaints reported as false positive and/or false negative patient results (confirmed and unconfirmed, conflicting results) related to kit lot 218193 showed that the complaint rate is (b)(4) respectively.Abbott diagnostics scarborough was unable to determine the exact root cause of the reported issue, however it could have possibly been related to the specific patient sample.H3 other text : single-use, device discarded.
 
Event Description
The consumer reported conflicting results with the binaxnow covid-19 antigen self-test performed on (b)(6) 2024 using tests from the same lot.The consumer stated the first test generated a positive result and the second test generated a negative result.No other testing was performed.The consumer stated the patient was asymptomatic.The customer confirmed there was no patient harm due to the test results.No additional patient information, including treatment and outcome, was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BINAXNOW COVID-19 AG SELF TEST 2CT
Type of Device
CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
Manufacturer (Section D)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough ME 04074
Manufacturer Contact
rachel blackwell
10 southgate road
scarborough, ME 04074
6613888803
MDR Report Key18872188
MDR Text Key337301526
Report Number1221359-2024-00252
Device Sequence Number1
Product Code QKP
UDI-Device Identifier00811877011408
UDI-Public00811877011408
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EUA210264
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 03/20/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date05/14/2024
Device Catalogue Number195-160
Device Lot Number218193
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/22/2024
Initial Date FDA Received03/10/2024
Supplement Dates Manufacturer Received03/14/2024
Supplement Dates FDA Received03/20/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age59 YR
Patient SexFemale
Patient Weight84 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-